価格表

在庫・価格 : 2025年10月08日 07時42分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Mouse VEGF R1/Flt-1 Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF471-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000 1個 追加

在庫・価格 : 2025年10月08日 07時42分 現在

Anti-Mouse VEGF R1/Flt-1 Affinity Purified Polyclonal Ab

  • 商品コード:AF471-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Zhao F et al. Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering. J Tissue Eng ;10:2041731419891256
Zhao F et al
Species: Rat, Applications: Neutralization PubMed
2 Verma M et al. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy. PLoS Genet 2019 12;15(12):e1008468
Verma M et al
2019/01/01
Species: Mouse, Applications: IHC frozen fixed PubMed
3 Ambati BK et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006 Oct;443(7114):993-7
Ambati BK et al
2006/01/01
Species: Mouse, Applications: Neutralization PubMed
4 Teixeira SC et al. Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy. Sci Rep 2017 Mar;7:44978
Teixeira SC et al
2017/01/01
Species: Mouse, Applications: Western Blot PubMed
5 Li Y et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J. Clin. Invest. 2008 Mar;118(3):913-23
Li Y et al
2008/01/01
Species: Mouse, Applications: Neutralization PubMed
6 Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
Le Bras B et al
2006/01/01
Species: Mouse, Applications: IHC-Fr PubMed
7 Usui T et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 2004 Feb;45(2):368-74
Usui T et al
2004/01/01
Species: Mouse, Applications: Neutralization PubMed
8 Roda JM et al. Hypoxia-inducible factor-2? regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. J. Immunol. 2011 Aug;187(4):1970-6
Roda JM et al
2011/01/01
Species: Mouse, Applications: Neutralization PubMed
9 Eubank TD et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res. 2009 Mar;69(5):2133-40
Eubank TD et al
2009/01/01
Species: Mouse, Applications: Neutralization PubMed
10 Hou ST et al. Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage. Sci Rep 2015;5:7890
Hou ST et al
2015/01/01
Species: Rat, Applications: Bioassay PubMed
11 Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
Cianfarani F et al
2006/01/01
Species: Mouse, Applications: ELISA Development PubMed
12 Nozaki M et al. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J. Clin. Invest. 2006 Feb;116(2):422-9
Nozaki M et al
2006/01/01
Species: Mouse, Applications: Immunoprecipitation PubMed
13 Gerhardt H et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003 Jun;161(6):1163-77
Gerhardt H et al
2003/01/01
Species: Rat, Applications: Neutralization PubMed
14 Hudson N et al. Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev. Cell 2014 Sep;30(5):541-52
Hudson N et al
2014/01/01
Species: Mouse, Applications: IHC-Fr PubMed
15 Gudehithlu KP et al. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. J. Lab. Clin. Med. 2005 Apr;145(4):194-203
Gudehithlu KP et al
2005/01/01
Species: Rat, Applications: IHC-P PubMed
16 Dikov MM et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J. Immunol. 2005 Jan;174(1):215-22
Dikov MM et al
2005/01/01
Species: Mouse, Applications: Western Blot PubMed
17 Benedito R et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 2012 Apr;484(7392):110-4
Benedito R et al
2012/01/01
Species: Mouse, Applications: Immunoprecipitation PubMed
18 Zhang Z et al. alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 2008 Feb;111(4):1980-8
Zhang Z et al
2008/01/01
Species: Mouse, Applications: Western Blot PubMed
19 Mohamedali KA et al. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel. Cancer Res. 2006 Nov;66(22):10919-28
Mohamedali KA et al
2006/01/01
Species: Mouse, Applications: Neutralization PubMed
20 Silvestre JS et al. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ. Res. 2003 Jul;93(2):114-23
Silvestre JS et al
2003/01/01
Species: Mouse, Applications: Neutralization PubMed
21 Matsuno H et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002 Oct;100(7):2487-93
Matsuno H et al
2002/01/01
Species: Mouse, Applications: Neutralization PubMed
22 Schreurs MP et al. The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy. FASEB J. 2012 Jan;26(1):355-62
Schreurs MP et al
2012/01/01
Species: Rat, Applications: Neutralization PubMed
23 Carmi Y et al. The Role of IL-1β in the Early Tumor Cell-Induced Angiogenic Response. J. Immunol. 2013 Apr;190(7):3500-9
Carmi Y et al
2013/01/01
PubMed
24 Yao H et al. Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: involvement of β1 integrins. FASEB J. 2013 Apr;27(4):1532-48
Yao H et al
2013/01/01
Species: Rat, Applications: Neutralization PubMed
25 Shin JY et al. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells. Cell. Immunol. 2009;256(1-2):72-8
Shin JY et al
2009/01/01
Species: Mouse, Applications: Neutralization PubMed
26 Ola R et al. PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat Commun 2016 Nov;7:13650
Ola R et al
2016/01/01
Species: Mouse, Applications: IHC PubMed
27 Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
Marko SB et al
2008/01/01
Species: Rat, Applications: ICC PubMed
  • No.: 1
  • 文献情報:
    Zhao F et al. Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering. J Tissue Eng ;10:2041731419891256
    Zhao F et al
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Verma M et al. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy. PLoS Genet 2019 12;15(12):e1008468
    Verma M et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: IHC frozen fixed
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ambati BK et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006 Oct;443(7114):993-7
    Ambati BK et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Teixeira SC et al. Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy. Sci Rep 2017 Mar;7:44978
    Teixeira SC et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Li Y et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J. Clin. Invest. 2008 Mar;118(3):913-23
    Li Y et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
    Le Bras B et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Usui T et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 2004 Feb;45(2):368-74
    Usui T et al
    2004/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Roda JM et al. Hypoxia-inducible factor-2? regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. J. Immunol. 2011 Aug;187(4):1970-6
    Roda JM et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Eubank TD et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res. 2009 Mar;69(5):2133-40
    Eubank TD et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Hou ST et al. Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage. Sci Rep 2015;5:7890
    Hou ST et al
    2015/01/01
  • 備考:
    Species: Rat, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
    Cianfarani F et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Nozaki M et al. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J. Clin. Invest. 2006 Feb;116(2):422-9
    Nozaki M et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: Immunoprecipitation
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Gerhardt H et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003 Jun;161(6):1163-77
    Gerhardt H et al
    2003/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hudson N et al. Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev. Cell 2014 Sep;30(5):541-52
    Hudson N et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Gudehithlu KP et al. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. J. Lab. Clin. Med. 2005 Apr;145(4):194-203
    Gudehithlu KP et al
    2005/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Dikov MM et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J. Immunol. 2005 Jan;174(1):215-22
    Dikov MM et al
    2005/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Benedito R et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 2012 Apr;484(7392):110-4
    Benedito R et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: Immunoprecipitation
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Zhang Z et al. alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 2008 Feb;111(4):1980-8
    Zhang Z et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Mohamedali KA et al. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel. Cancer Res. 2006 Nov;66(22):10919-28
    Mohamedali KA et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Silvestre JS et al. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ. Res. 2003 Jul;93(2):114-23
    Silvestre JS et al
    2003/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Matsuno H et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002 Oct;100(7):2487-93
    Matsuno H et al
    2002/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Schreurs MP et al. The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy. FASEB J. 2012 Jan;26(1):355-62
    Schreurs MP et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Carmi Y et al. The Role of IL-1β in the Early Tumor Cell-Induced Angiogenic Response. J. Immunol. 2013 Apr;190(7):3500-9
    Carmi Y et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Yao H et al. Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: involvement of β1 integrins. FASEB J. 2013 Apr;27(4):1532-48
    Yao H et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Shin JY et al. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells. Cell. Immunol. 2009;256(1-2):72-8
    Shin JY et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Ola R et al. PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat Commun 2016 Nov;7:13650
    Ola R et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
    Marko SB et al
    2008/01/01
  • 備考:
    Species: Rat, Applications: ICC
  • 参照:
    PubMed